BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766 AND Staging
2622 results:

  • 1. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.
    Lee JW; Ahn H; Yoo ID; Hong SP; Baek MJ; Kang DH; Lee SM
    Cancer Imaging; 2024 Apr; 24(1):53. PubMed ID: 38627864
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
    Soomro MY; Khan SR; Muhammad H; Ahmad S; Zehra N; Ali I; Samar MR; Hameed A; Moosajee M; Rashid YA
    BMC Cancer; 2024 Apr; 24(1):479. PubMed ID: 38627736
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
    Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
    World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. True significance of the number of retrieved lymph nodes in stage II colon cancer resected by minimally invasive surgery: Influence of tumor sidedness.
    Iguchi K; Sugiyama A; Mushiake H; Hasegawa S; Rino Y; Saito A; Shiozawa M
    Asian J Endosc Surg; 2024 Jul; 17(3):e13312. PubMed ID: 38626926
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
    Rao C; Tong J; Yang Y
    Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Application value of laparoscopic double stapler firings and double stapling technique combined with rectal eversion and total extra-abdominal resection in the sphincter-preserving resection of low rectal cancer].
    Liang H; Wu KQ; Fan QW; Zheng W; Zhang H; Bai JW; Li JM; Chen JQ; Zhang C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):283-286. PubMed ID: 38532592
    [No Abstract]    [Full Text] [Related]  

  • 7. Comparison of conventional unstained lymph nodal harvesting vs methylene blue-stained lymph nodal harvesting in colorectal specimen in staging left-sided colorectal carcinoma: a randomized controlled trial.
    Chilaka S; Samuel EMK; Mude NN; G B; Badhe B; Nagarajan RK
    J Gastrointest Surg; 2024 Mar; 28(3):199-204. PubMed ID: 38445909
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Watch and Wait for Rectal cancer].
    Kastner C; Meir M; Flemming S; Reibetanz J; Germer CT; Wiegering A
    Zentralbl Chir; 2024 Feb; 149(1):75-82. PubMed ID: 38442886
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A prediction nomogram for perineural invasion in colorectal cancer patients: a retrospective study.
    Que Y; Wu R; Li H; Lu J
    BMC Surg; 2024 Mar; 24(1):80. PubMed ID: 38439014
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pathological characteristics and long-term prognosis of submucosal infiltrating carcinoma of the colon and rectum below 2 cm confirmed by endoscopic submucosal dissection.
    Zhou J; Ling T; Xiao J; Zhang Q; Wang L
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):275-280. PubMed ID: 38431836
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic implications of T stage in different pathological types of colorectal cancer: an observational study using SEER population-based data.
    Yao N; Li W; Wang J; Chu H; Duan N; Niu X; Yu G; Qu J
    BMJ Open; 2024 Feb; 14(2):e076579. PubMed ID: 38423773
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
    Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L
    Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Multicenter Evaluation of a Weakly Supervised Deep Learning Model for Lymph Node Diagnosis in Rectal cancer at MRI.
    Xia W; Li D; He W; Pickhardt PJ; Jian J; Zhang R; Zhang J; Song R; Tong T; Yang X; Gao X; Cui Y
    Radiol Artif Intell; 2024 Mar; 6(2):e230152. PubMed ID: 38353633
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. What is your count? An observational study of lymph node counting in 2,028 colorectal cancer resections.
    Srivastava S; Kak I; Major P; Bonert M
    PLoS One; 2024; 19(2):e0295209. PubMed ID: 38329946
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. IMPACT OF THE COVID-19 PANDEMIC ON THE EMERGENCY SURGICAL TREATMENT OF colorectal cancer.
    Kanno DT; Mattos RLM; Siqueira RM; Pereira JA; Campos FG; Martinez CAR
    Arq Bras Cir Dig; 2024; 36():e1793. PubMed ID: 38324854
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Magnetic resonance imaging for assessment of rectal cancer nodes after chemoradiotherapy: A single center experience.
    Barbaro B; Carafa MRP; Minordi LM; Testa P; Tatulli G; Carano D; Fiorillo C; Chiloiro G; Romano A; Valentini V; Gambacorta MA
    Radiother Oncol; 2024 Apr; 193():110124. PubMed ID: 38309586
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Factors affecting survival in stage 2-3 colorectal cancer: a single-center retrospective study.
    Karahan M; Mulkut F; Okut G
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):615-621. PubMed ID: 38305605
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Spigelman staging System and the Risk of Duodenal and Papillary cancer in Familial Adenomatous Polyposis: A Systematic Review and Meta-Analysis.
    Mannucci A; Puzzono M; Goel A; Möslein G; Balafas S; Di Serio MS; Cavestro GM
    Am J Gastroenterol; 2024 Apr; 119(4):617-624. PubMed ID: 38294150
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Glutaredoxin 2 Protein (Grx2) as an Independent Prognostic Factor Associated with the Survival of Colon Adenocarcinoma Patients.
    Brzozowa-Zasada M; Piecuch A; Bajdak-Rusinek K; Gołąbek K; Michalski M; Janelt K; Matysiak N
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256132
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Prognostic Activity of Glutaredoxin 1 Protein (Grx1) in Colon cancer.
    Brzozowa-Zasada M; Piecuch A; Bajdak-Rusinek K; Gołąbek K; Michalski M; Matysiak N; Czuba Z
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256082
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 132.